Ipsen
The Global Asset Lead for Iqirvo at Ipsen will be accountable for the vision, strategy, and value creation of a critical rare disease asset, guiding it from development through commercialization. This senior leader will steer a cross‑functional global team, align stakeholders, and ensure delivery against milestones across the product lifecycle.
Headquarters
Paris, Île-De-France, France
Company Size
5001-10000 employees
Founded
1929
Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ipsen.
Ipsen didn’t post a salary, so this is our estimate from similar listings.
40% above the average for this role
IPSEN (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened
9 hours ago
Global Medical Affairs Asset Lead (GMAL) Rare Disease
lifelancer
Director, Clinical Development
Acadia Pharmaceuticals Inc.
Global Medical Scientist
Ascendis Pharma
Global Medical Affairs Asset Lead (GMAL) Rare Disease
Amgen
Global Medical Scientist - Job ID: 1986
Ascendis Pharma
Global Marketing Partner
AstraZeneca